Kymab, LifeArc form medicines discovery alliance
The partnership provides LifeArc with access to Kymab’s suite of antibody discovery technologies, including Darwin.
Read More
Tag: Transgenics
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
